Vytalize Health gains $50 million in its Series B funding round

Value-based care startup Vytalize Health brings in $50 million in its Series B funding round led by Enhanced Healthcare Partners.

Value-based care startup Vytalize Health brings in $50 million in its Series B funding round led by Enhanced Healthcare Partners. Other participants of the round are Kittyhawk Ventures, Kawn Ventures, North Coast Ventures and others.

The New York-based venture was established by Amer Alnajar, Faris Ghawi, Hasan Bayat, and Omar Elrabiein in 2014. They aim to take care of the doctors who take care of us. They have specialised in Medicare services which allows them to offer a unique solution that is both efficient and effective.

In 2018. They gained an undisclosed number in a Non-equity Assitance round by Dreamit Ventures. In 2020, they gained a seed fund of $5.5 million led by Hudson River Capital Partners. Last year in Jan, they raised $17 million in their Series A round led by KittyHawk Ventures. 

Last year in February, Vytalize Health acquired MedPilot. MedPilot had over a million patients and had showcased 97% of patient satisfaction score. Previously this startup had raised $3.5 million from prominent investors, including Hudson River Capital, Wavemaker 360 Health and others.

The company claims that it has partnered with over 280 primary care practices in 15 plus states. Their patient base is witnessing 150% growth year on year. They have over 65,000 Medicare patients and manage around $2 billion in medical spending.

Tags : #VytalizeHealth #AmerAlnajar #FarisGhawi #HasanBayat #OmarElrabiein #value-based-care #startup #funding #fundingalert #smitakumar #medicircle

Related Stories

14 Feb

Novartis India Limited signs exclusive sales and distribution agreement with Dr. Reddy’s Laboratories

Latest corporate news update; Pharma

View
03 Feb

European Commission approves Teysuno in metastatic colorectal cancer

Latest Corporate news updates; Pharma Feb 3rd 2022

View
24 Dec

Novartis acquires a gene-therapy company Gyroscope Therapeutics

Swiss healthcare giant Novartis has agreed to pay $1.5 billion to acquire British biotech company Gyroscope Therapeutics.

View
31 Aug

ImmixBio and BeiGene to evaluate combination of IMX-110 and Tislelizumab in solid tumors

Latest Pharma News Update

View
02 Aug

GSK and Vir Biotechnology announce joint procurement agreement with European Commission for COVID-19 treatment, Sotrovimab

Latest pharma news update

View
21 Jun

Novartis receives FDA approval 177Lu-PSMA-617 for metastatic castration resistant prostate cancer

FDA breakthrough therapy for Novartis metastatic prostate cancer drug

View
08 May

Roche’s Tecentriq approved by European Commission for metastatic non-small cell lung cancer

Tecentriq is now the first and only single-agent cancer immunotherapy with three dosing options

View
25 Mar

Novartis announces positive result of phase III study with radioligand therapy 177Lu-PSMA-617

The study is aimed for patients with advanced prostate cancer

View
15 Feb

Xeris Pharmaceuticals receives approval from the European Commission for Ogluo

Ogluo (Glucagon) is indicated treatment of severe hypoglycemia

View
10 Feb

Novartis receives FDA Breakthrough Therapy designations for STAMP inhibitor asciminib (ABL001)

Novartis receives FDA Breakthrough Therapy designations for investigational STAMP inhibitor asciminib (ABL001) in chronic myeloid leukaemia

View

-Advertisements-




Trending Now

Maternal and Infant Health in Focus as India Observes World Health Day 2025April 05, 2025
Under 15 Children Under Threat: The TB Comeback No One Saw Coming April 04, 2025
MGM Healthcare Performs World's First Modified Multi-Visceral Transplant for Rare Intestinal DisorderApril 04, 2025
World Health Day 2025: St. George’s University’s Role in Preparing Doctors to Tackle Global Health ChallengesApril 04, 2025
Strength Doesn’t Retire: The Science Behind Ageless PowerApril 04, 2025
Beyond the Baby Bump: Can Delayed Pregnancy Increase Autism Risk in ChildrenApril 04, 2025
University of Manchester invites applications for MA Social AnthropologyApril 03, 2025
Ahead of World Health Day, Sova Health Launches Advanced Microbiome Tests & Evidence-Based Precision Supplements April 03, 2025
Half of women cannot make decisions about their reproductive health and bodily autonomyApril 03, 2025
UGRO CAPITAL LIMITED PUBLIC ISSUE OF SECURED, RATED, LISTED, REDEEMABLE, NON-CONVERTIBLE DEBENTURES (SECURED NCDS) OPENS TODAY EFFECTIVE ANNUALIZED YIELD UP TO 11.01% PER ANNUM* April 03, 2025
SF Airlines Entrusts Çelebi India with Freighter Handling at Kempegowda International Airport, BengaluruApril 03, 2025
Is This the Future of Physiotherapy? Inside Stance Health’s $1M ExpansionApril 03, 2025
The Daily Shower Debate: Are You Washing Away Your Skin’s Health?April 03, 2025
The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025